FDA proposes unique ID system for devices; Northwestern develops super-flexible implantables;

@FierceMedDev: CareFusion has staged a Class I recall of some of its infant breathing devices. Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: Roche continues to expand its diagnostics business with an FDA nod for a new HIV test. Story | Follow @DamianFierce

> The FDA is proposing every medical device marketed in the U.S. feature a unique ID tag, looking to improve reporting of adverse events and device safety. The agency will seek comment on the proposal for 120 days. Statement

> W.L. Gore has received a CE mark for expanded sizes of its Excluder AAA endoprosthesis, a device designed to treat abdominal aortic aneurysm. More

> Researchers at Northwestern University have developed electronics that can stretch to more than 200% their original size, a development that could lead to super-flexible medical devices. Article

> Syneron Medical ($ELOS) has received FDA clearance for its Elos Plus system, a multi-platform dermatological tech used in aesthetic procedures. The device is already available in Europe and Asia. News

> ProPep Surgical received 510(k) clearance for its nerve monitoring system, an intraoperative tech designed to accompany robotic prostate cancer surgery. Release

Pharma News

 @FiercePharma: Jefferies analysts like India's Cipla, Ranbaxy, Sun Pharma, because of emerging markets sales. Item | Follow @FiercePharma

> Will Amylin buy favor AZ's Simon Lowth in CEO contest? More

> Purdue aims to extend OxyContin monopoly with test in kids. Article

> Icahn looks askance at Forest CEO's stock trading. Story

Biotech News

 @FierceBiotech: Researchers shatter record with U.S.-China genomic data transfer. News | Follow @FierceBiotech

 @JohnCFierce: Rodman's Michael King says 'whoops' on Amylin, believes Vivus and MannKind (huh?) next likely diabetes targets. Item | Follow @JohnCFierce

 @RyanMFierce: A good job rounding up the early-stage biotech VC usual suspects. More | Follow @RyanMFierce

> GlobeImmune's $69M IPO designed to build immunotherapy pipeline. Article

> In R&D showdown, Genentech beat Roche in a TKO. Story

> J&J rushes drug-resistant TB therapy bedaquiline to FDA. News

Biotech Research News

> Promising mouse study lays foundation for startup's autism drug program. Article

> In breakthrough, stem cell transplants reverse diabetes in mice. Story

> Texas cancer research funding effort may shift to startups. Item

> Mayo Clinic researchers find novel way to repair MS damage. News

Pharma Manufacturing News

> GlaxoSmithKline's Witty says manufacturing must become more efficient. More

> J&J recalls 69,000 units of K-Y vaginal lubricant. News

> United snags Glaxo buildings as it completes expansion. Story

> ScinoPharm building new cancer injectables plant in China. Article

Biomarkers News

> Marker helps docs pick kids' bone cancer treatment. Story

> Developing proteomic signatures focus pancreatic cancer therapy. Article

> Heart size distorts biomarker levels. More

> Apolipoproteins mark diabetic visual loss. Item

> Biomarkers spot hep C liver disease. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.